Globus Medical
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Globus Medical sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
Globus Medical: 10 sponsored US clinical trials, 1 recruiting.
Globus Medical sponsors 10 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 6 completed. The most-studied condition in this pipeline is Idiopathic Scoliosis, with 1 trials.
Top-decile sponsor footprint
Globus Medical ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
10 total, page 1 of 1
REFLECT Scoliosis System Post Approval Study
NCT06298812
A Retrospective Review: Outcomes of the REFLECT™ System for Idiopathic Scoliosis
NCT07589023
Amnios™ RT Outcomes Study
NCT04088383
A Prospective Randomized Postmarket Clinical Study of the TRANSITION Stabilization System
NCT02184520
Treatment of Sacroiliac Dysfunction With SI-LOK® Sacroiliac Joint Fixation SI-SI-LOK
NCT01861899
Study of an Expandable Interbody Device for the Lumbar Spine
NCT02075554
INDEPENDENCE Spacer for Lumbar Fusion
NCT02299323
TRIUMPH Lumbar Artificial Disc IDE: A Pilot Study
NCT01198470
Study Evaluating the Safety and Effectiveness of the FLEXUS(TM) Interspinous Spacer
NCT01156675
A Pivotal Study of a Facet Replacement System to Treat Spinal Stenosis
NCT00401518
Therapeutic Areas
What is open in the Globus Medical pipeline
1 recruiting of 10 indexed (10% open); 6 completed (60%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Idiopathic Scoliosis (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Globus Medical: open-pipeline peers nationwide
Peers matched on 10 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
Globus Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 trials (± recruiting share)
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Abiomed · 10% recruiting · 20 trials
- Aimmune Therapeutics · 10% recruiting · 10 trials
- Altria Client Services · 10% recruiting · 10 trials
- Alzheimer's Disease Cooperative Study (ADCS) · 10% recruiting · 10 trials
Related
What to do with this Globus Medical page
10 registered trials is a research-attention snapshot, not an endorsement of Globus Medical or any single study.
- 1 of Globus Medical's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Idiopathic Scoliosis is the condition Globus Medical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Idiopathic Scoliosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Globus Medical pipeline card: 10 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.